Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose Monitoring
figure
posted on 2020-10-14, 09:43 authored by Yuji Kawaguchi, Jun Sawa, Yasuro Kumeda<p>The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).<br></p>
<p>© The authors, CC-BY-NC 2020.</p>
<b><br>
</b>
<p><b> </b></p>
